PAX Neuroscience
Biotechnology Research • 
United States • 1-10 Employees
Company overview
| Headquarters | United States |
| Phone number | +12023200392 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Founded | 2009 |
| Employees | 1-10 |
| Socials |
Key Contacts at PAX Neuroscience
Barry Frankel
Chief Executive Officer, Member Board Of Directors
Robert Friesen
Chief Operating Officer, Member Board Of Directors Ex Officio
PAX Neuroscience Email Formats
PAX Neuroscience uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@paxneuroscience.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@paxneuroscience.com | 100% |
About PAX Neuroscience
The WHO estimates that by 2020, depression will be the leading cause of disability worldwide. Pax Neuroscience, Inc. is a clinical diagnostics company focused on development and commercialization of blood tests for depression diagnosis and for antidepressant response. These tests are based on novel protein biomarkers derived from hypothesis-driven data sets and early clinical results are promising.
PAX Neuroscience revenue & valuation
| Annual revenue | $30,400,000 |
| Revenue per employee | $4,337,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $97,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
PAX Neuroscience has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
PAX Neuroscience has never raised funding before.
Canada
United Kingdom
Saudi Arabia
Frequently asked questions
4.8
40,000 users
